Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Abatacept may help some people with alopecia areata regrow hair.

Abrocitinib may effectively treat stubborn alopecia universalis.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Microneedle patches with alpha-arbutin and resveratrol can effectively reduce skin pigmentation without irritation.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

JAK inhibitors may help improve symptoms in adults with APECED.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

17β-estradiol can reduce inflammation in the skin.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Biosimilars lower costs but don't significantly improve access.

The combination of encorafenib and binimetinib caused few skin issues.

The method effectively showed that the two exemestane preparations are bioequivalent.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

XEDAR triggers a specific signaling pathway in cells.